Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Affordable proteomics: the two-hybrid systems.

Marc Gillespie¹

¹Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health, St John's University, 8000 Utopia Parkway, Jamaica, NY 11439, USA. gillespm@stjohns.edu

Current Opinion in Molecular Therapeutics

|July 23, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Application of Large Language Models for Annotating Genes into Reactome Pathways.

bioRxiv : the preprint server for biology·2026

Same author

The Reactome Knowledgebase 2026.

Nucleic acids research·2025

Same author

The Reactome Pathway Knowledgebase 2024.

Nucleic acids research·2023

Same author

Pathway-based, reaction-specific annotation of disease variants for elucidation of molecular phenotypes.

bioRxiv : the preprint server for biology·2023

Same author

Using the Reactome Database.

Current protocols·2023

Same author

Incorporation and Assessment of Portable Tablet Technology During a Patient Counseling Exercise.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2021

Same journal

Gene therapy: Have the risks associated with viral vectors been solved?

Current opinion in molecular therapeutics·2011

Same journal

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Current opinion in molecular therapeutics·2010

Same journal

Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

Current opinion in molecular therapeutics·2010

Same journal

Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

Current opinion in molecular therapeutics·2010

Same journal

Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

Current opinion in molecular therapeutics·2010

Same journal

Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

Current opinion in molecular therapeutics·2010

See all related articles

The two-hybrid system offers an affordable and accessible proteomic approach for identifying protein interactions. This method empowers laboratories to conduct pilot studies for biomarker discovery and target identification.

Area of Science:

Biochemistry
Molecular Biology
Proteomics

Background:

Advanced proteomic techniques often demand significant expertise and financial investment, limiting their accessibility.
This restricts the use of proteomics for initial biomarker or target identification in many labs and smaller companies.

Purpose of the Study:

To highlight the utility of the two-hybrid system as a practical and accessible proteomic tool.
To demonstrate its potential for biomarker and target identification in various research fields.

Main Methods:

The study focuses on two-hybrid systems, a proteomic approach.
Compares its feasibility, scale, and cost-effectiveness to other proteomic tools.
Discusses the availability of foundational kits for two-hybrid investigations.

Related Experiment Videos

Main Results:

Two-hybrid systems, originally designed as practical screens, are affordable and technically feasible.
These systems rapidly identify previously uncharacterized protein interactions.
The portability of the two-hybrid system allows for in-house evaluation of proteomic data.

Conclusions:

The two-hybrid system democratizes proteomics, making it accessible for pilot studies.
It enables researchers to conduct protein interaction studies and identify potential biomarkers or drug targets.
This technique empowers laboratories to integrate proteomic investigations into their existing research frameworks.